Conditions: Crohn's Disease
Keywords: gastrointestinal GI Crohn's disease Japan Japanese
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 75
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether treatment with D9421-C for 8 weeks in Japanese patients with mild to moderate active Crohn's disease will improve their symptoms of Crohn's disease and quality of life.

Detailed description:

Arms:
arm 1: D9421-C 9 mg arm 2: D9421-C 15 mg arm 3: Placebo

Interventions: intervention 1: D9421-C, 9mg intervention 2: D9421-C, 15mg intervention 3: Placebo
Intervention descriptions: intervention 1: D9421-C 9 mg was given once daily for 8 weeks. intervention 2: D9421-C 15 mg was given once daily for 8 weeks. intervention 3: D9421-C matching placebo was given once daily for 8 weeks.

Protocol document: